ProfileGDS5678 / 1423782_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 96% 97% 97% 97% 97% 97% 96% 97% 97% 96% 96% 96% 96% 97% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 18.9356396
GSM967853U87-EV human glioblastoma xenograft - Control 29.1367497
GSM967854U87-EV human glioblastoma xenograft - Control 39.1784497
GSM967855U87-EV human glioblastoma xenograft - Control 49.533397
GSM967856U87-EV human glioblastoma xenograft - Control 59.2136297
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 18.9044497
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 28.6713296
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 39.0857397
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 49.1793997
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 18.902696
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 28.8048396
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 38.9076996
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 48.9614296
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 59.1014297